Survey 24 - DentalMCI Registration NumberFULL NAME (As in your Pancard)EmailPhone/MobileCityStateSpecialityBank DetailsAccount Holder NameA/c NumberIFSC CodeUpload Cancelled Cheque (Max Size - 2 MB)Choose File Pancard NumberUpload Pancard Details (Max Size - 2 MB)Choose File Clinical Role of Aceclofenac, Paracetamol, and Serratiopeptidase Combination in Managing Dental Pain and Inflammation1. What percentage of your dental patients present with cardiac or renal comorbidities? Less than 10% 10-30% 30-50% More than 50%2. How frequently do you encounter cases of dental pain and inflammation in such patients? Rarely Occasionally Often Very often3. Which medications do you typically prescribe for dental pain and inflammation in patients with comorbidities? NSAIDs (Ibuprofen, Diclofenac, etc.) Aceclofenac-Paracetamol-Serratiopeptidase combination Paracetamol alone Other4. What factors guide your choice of medication in these cases? Efficacy in pain relief Safety profile for comorbidities Patient affordability Availability5. How would you rate the efficacy of the Aceclofenac-Paracetamol-Serratiopeptidase combination in managing dental pain? Poor Fair Good Excellent6. In your experience, how effective is this combination in reducing inflammation? Not effective Somewhat effective Effective Very effective7. What is your primary concern when prescribing medications for patients with cardiac comorbidities? Cardiovascular side effects Drug interactions with existing medications Efficacy of pain relief Other8. What is your primary concern when prescribing medications for patients with renal comorbidities? Nephrotoxicity Dosage adjustments Drug-drug interactions Other9. How do you evaluate the safety profile of the Aceclofenac-Paracetamol- Serratiopeptidase combination for such patients? Poor Fair Good Excellent10. Do you adjust the dosage of this combination for patients with cardiac or renal issues? Always Sometimes Rarely Never11. How often do you monitor these patients for adverse reactions after prescribing this combination? Never Occasionally Often Always12. Have you encountered any adverse reactions linked to this combination in these patients? Yes, often Yes, occasionally Rarely Never13. Which adverse effects have you observed most commonly with this medication combination? Gastrointestinal issues Cardiovascular complications Renal dysfunction Other14. How satisfied are your patients with the pain and inflammation management using this combination? Very dissatisfied Dissatisfied Satisfied Very satisfied15. Do you consider this combination as a first-line treatment for dental pain in such cases? a) Yes b) No16. What are the alternative therapies you recommend in case of contraindications to this combination? Monotherapy (Paracetamol or Aceclofenac) Physical therapies Other NSAIDs Other17. What is your perception of patient adherence to this combination therapy? Poor Fair Good Excellent18. Do you provide special dietary or medication advice for these patients to minimize risks? Yes No19. How often do you educate patients on the potential risks and benefits of this medication? Always Often Occasionally Rarely20. What is your overall perception of the clinical role of this combination in managing dental pain and inflammation for patients with cardiac or renal comorbidities? Ineffective Somewhat effective Effective Highly effective I have read and agree to the Terms and Conditions .Submit Form